2.12
price up icon6.00%   0.12
after-market Handel nachbörslich: 2.10 -0.02 -0.94%
loading

Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
327.09%
137.74
32.25 33.97 25.79 24.33
Cost Of Revenue
53.47
- - - -
Gross Profit
91.46
- - - -
Operating Expenses
12.26%
65.47
74.62 61.50 62.84 72.93
Interest Income/Expense
6.86%
14.02
15.06 14.99 14.54 14.39
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
12.26%
65.47
74.62 61.50 62.84 72.93
Operating Income/Loss
270.58%
72.27
-42.37 -27.53 -37.06 -48.60
Income/Loss From Continuing Operations Before Tax
327.09%
137.74
32.25 33.97 -49.94 -61.72
Income Tax Expense/Benefit, Deferred
-4.412
- - - -
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
208.30%
61.02
-56.34 -41.25 -49.94 -61.72
Net Income/Loss
208.30%
61.02
-56.34 -41.25 -49.94 -61.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,302%
169.26
3.133 111.87 109.24 78.44
Diluted Average Shares
5,953%
189.64
3.133 111.87 109.24 78.44
Basic Earnings Per Share
172.00%
0.36
-0.50 -0.37 -0.46 -0.79
Diluted Earnings Per Share
168.00%
0.34
-0.50 -0.37 -0.46 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$12.67
price up icon 0.88%
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Kapitalisierung:     |  Volumen (24h):